Cytiva Fibro PrismA antibody purification technology
Cytiva’s Fibro PrismA antibody purification technology has been designed to support the industry’s drive for increased speed and flexibility, in order to advance the development of novel therapeutics. The first product based on the company’s protein A fibre chromatography technology, it is being used to accelerate research for customers and collaborators.
Fibro chromatography technology enables rapid cycling antibody purification. In research and process development, this means Fibro PrismA can support up to 20 times increased throughput compared with traditional resins, the company claims. In clinical and commercial manufacturing, the technology will enable efficient single-use operations, by using the full unit lifetime in a single batch.
Fibro PrismA enables ultrafast purification in research and process development, allowing researchers to accelerate the drug discovery process. Clinical-scale products are set to follow.
Phone: 1800 150 522
CoolLED pE-300white LED illumination system for fluorescence microscopy
The system delivers powerful, broad-spectrum LED illumination designed for fluorescence...
BUCHI ProxiMate and ProxiScout NIR systems
ProxiMate is an at-line NIR instrument specifically designed for the food and feed industry,...
LICORbio Atlas for 2D and 3D cell imaging
Designed for both 2D and 3D assays, the product delivers high-content, high-throughput imaging in...